Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Eloxx Pharmaceuticals Q4 EPS $(0.14) Misses $(0.12) Estimate

Eloxx Pharmaceuticals (NASDAQ:ELOX) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.12) by 16.67 percent. This is a 6.67 percent increase over losses of $(0.15) per share

byBenzinga Newsdesk

March 31, 2022

1 minute read

Eloxx Pharmaceuticals (NASDAQ:ELOX) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.12) by 16.67 percent. This is a 6.67 percent increase over losses of $(0.15) per share from the same period last year.